U.S. Stocks to Watch: Trade Desk, Expedia, Pinterest, Twilio, Gilead Sciences and More

Dow Jones
2025/08/08

Stock futures were pointing higher while the dollar fell early Friday, ending a week marked by trade developments and geopolitical events, as well as a flurry of company earnings.

These stocks were making moves in premarket trading Friday:

Trade Desk stock plummeted 29% despite posting solid second-quarter earnings. The ad-tech company announced that CFO Laura Schenkein will be replaced by Alex Kayyal—a board member who spent nearly a decade at Salesforce in executive roles—on Aug. 21. Revenue came in at $694 million, up 19% from last year and ahead of expectations. Adjusted earnings per share were in line with expectations at 41 cents. The company also forecast revenue of at least $717 million in the current quarter, also in line with estimates.

Expedia Group soared 18% after the travel booking company raised its full-year outlook on the back of second-quarter earnings that beat expectations late Thursday. Adjusted earnings per share came in at $4.24 on revenue of $3.8 billion, beating analysts’s call of $3.97 a share on revenue of $3.7 billion and driven by strong business travel demand. It now sees 2025 revenue and gross booking growth of between 3% and 5% each, up from a range between 2% and 4%, previously.

Pinterest shares fell 13% after the photo-sharing website disappointed Wall Street with its latest earnings report. Second-quarter earnings were 33 cents a share on revenue of $998 million, below the of 35 cents a share on revenue of $975 million expected by analysts, according to FactSet.

Twilio reported earnings that beat expectations late Thursday, sending shares of the cloud communications company up 13% early Friday. Revenue in the second quarter rose 13% year-over year to $1.2 billion while adjusted earnings per share came in at $1.19, comfortably ahead of estimates of $1.05 a share, according to FactSet.

Gilead Sciences stock rose 2.9% after it raised guidance on the back of strong demand for its HIV medicine and solid quarterly earnings late Thursday. CEO Daniel O’Day told Barron’s that the recent launch of its HIV prevention shot Yeztugo had started off well.

Under Armour and Wendy’s were also slated to report quarterly earnings ahead of the bell Friday.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10